Groundbreaking New Study Elucidates the Impact of Adult Weight Gain on Cancer Risk Trajectories
Emerging research unveiled at the European Congress on Obesity (ECO) 2026 in Istanbul marks a significant advance in understanding how adult weight gain influences cancer risk over the life course. Conducted by Associate Professors Anton Nilsson and Tanja Stocks at Lund University’s Department of Translational Medicine, the expansive study assesses longitudinal weight trajectories from late adolescence through middle age, revealing stark correlations between progressive weight increases and heightened incidence of multiple cancers.
Obesity’s pervasive role as a global health challenge is well documented, currently affecting approximately one in eight individuals worldwide. Beyond its known metabolic consequences, obesity is increasingly recognized as a major oncogenic driver. The International Agency for Research on Cancer (IARC) has robustly linked excess adiposity with increased risks of cancers of the oesophagus (particularly adenocarcinoma), gastric cardia, colorectal region, liver, gallbladder, pancreas, postmenopausal breast, endometrium, ovaries, kidneys, meninges, thyroid gland, and hematologic malignancies such as multiple myeloma. However, many prior studies have examined obesity and cancer risk based on a snapshot of body weight at a single adult life stage, often neglecting the dynamic nature of weight changes across decades.
This latest investigation addresses this critical gap by leveraging the ODDS study—an extensive pooled, nationwide Swedish cohort—encompassing weight data from 1911 to 2020 combined with cancer registries extending through 2023. The dataset includes over 630,000 participants (251,041 men and 378,981 women), each with an average of four weight measurements taken between ages 17 and 60. By modeling individual weight trajectories over this 43-year span, the study elucidates nuanced associations between temporal weight gain patterns and site-specific cancer risk, shedding light on how the biology of adiposity’s oncogenic influence might vary by sex, cancer type, and timing of weight gain.
The data compellingly demonstrate that individuals in the highest quintile of adult weight gain face significantly elevated risks of developing several established obesity-related cancers, with men experiencing a 7% greater risk of any cancer and women a striking 17% increase compared to the lowest quintile. More dramatically, risks for firmly established obesity-related cancers spike by 46% in men and 43% in women within the highest weight gain category. Specific malignancies manifesting the most potent associations included liver and oesophageal adenocarcinoma in men, with hazard ratios of 2.67 and 2.25 respectively, and endometrial cancer in women with a hazard ratio of 3.78—indicating nearly quadruple the risk in the highest weight gain group.
Beyond these headline findings, moderate but statistically significant elevations in risk surfaced for gastric cardia and rectal cancers in men, postmenopausal breast cancer and meningioma in women, and colorectal and renal cell carcinomas in both sexes. Intriguingly, the study also identified cancers not previously classified as obesity-related but now showing meaningful associations with weight gain, such as pituitary tumors exhibiting more than a twofold increased risk in both sexes among high gainers, as well as men’s increased occurrences of malignant melanoma and diffuse large B-cell lymphoma, and women’s parathyroid gland tumors.
Another pivotal insight emerges from examining weight at age 17 before adulthood commenced. Here, the highest 20% cohort by weight similarly exhibited elevated cancer risks, often paralleling those attributable to adult weight gain. This suggests that both baseline adiposity entering adulthood and subsequent weight increases synergistically contribute to the lifetime cancer burden, challenging the emphasis on midlife body mass alone as a critical window for intervention.
The timing of weight gain throughout adulthood reveals additional complexity. The authors segmented adult life into early, middle, and later periods, discovering sex-specific and cancer-site specific patterns. For men, early and middle adulthood weight gain showed stronger associations with obesity-related cancers, especially for liver and oesophageal cancers. Conversely, for women, weight gain in middle to later adulthood periods was more strongly linked to endometrial, postmenopausal breast, and meningioma risks. When excluding female-specific cancers, women’s associations with weight gain were uniformly distributed across all age intervals, hinting at hormonal influences shaping these disparities.
Cancer etiologies appeared to interact differentially with the timing of adiposity increases. Renal cell carcinoma among men correlated most with early weight surge, liver and colon cancers aligned closely with middle adulthood changes in both sexes, and gastric cardia cancer alongside meningioma showed stronger trends with later adulthood weight gains. However, most of these distinctions did not reach strict statistical significance, underscoring the need for larger samples or alternative modeling approaches to fully elucidate these temporal nuances.
The analysis extended to age of obesity onset, revealing cancer incidence progressively increased the earlier obesity developed. Notably, men becoming obese before 30 years of age faced fivefold liver cancer risk, doubled pancreatic and renal cell cancer incidence, and a 58% increased colon cancer susceptibility. Women with early onset obesity experienced a 4.5-fold endometrial cancer risk, substantially heightened pancreatic and meningioma risks, and a doubled renal cell carcinoma risk compared to never-obese counterparts. These findings underscore the cumulative carcinogenic burden of prolonged excess adiposity, amplifying calls for early preventive interventions.
Mechanistically, the study’s results align with growing evidence that obesity-driven cancer pathogenesis is multifactorial. Key pathways implicated include dysregulated sex hormone metabolism, aberrant insulin signalling cascades, adipokine imbalances, and heightened systemic inflammation—each exerting tissue-specific oncogenic effects. In men, chronic inflammation and insulin resistance, compounded by gastroesophageal reflux disease in oesophageal adenocarcinoma, may explain the strong associations seen. For women, hormone-sensitive tumors involving endometrium and breast tissue reflect the pivotal role of excess adiposity in estrogen metabolism and receptor activation. Additionally, novel associations with pituitary tumors invite further exploration into neuroendocrine mechanisms modulated by obesity.
The investigators conclude that a life-course perspective on weight management is paramount in cancer prevention strategies. Their comprehensive longitudinal analysis emphasizes that both early adult body weight and subsequent weight gain exert substantial influences on risks across a spectrum of established and emerging obesity-related cancers. Given the ongoing global rise in obesity prevalence and its intersection with increasing cancer incidence, the findings provide compelling impetus to implement timely, sex-aware, and sustained weight control measures throughout adulthood.
This research represents a paradigm shift toward integrating temporal weight trajectories into oncologic risk assessment and public health policies. It lays the groundwork for future mechanistic studies and clinical trials aimed at disentangling the complex interplay of adiposity and carcinogenesis, ultimately elevating precision prevention in oncology.
For further information, the full preprint is available at medRxiv, and the authors welcome inquiries regarding this transformative work.
Subject of Research:
Longitudinal impact of adult weight gain on incidence of established and potential obesity-related cancers.
Article Title:
Not specified in the provided content.
News Publication Date:
May 2026 (in conjunction with ECO 2026, 12-15 May).
Web References:
https://www.medrxiv.org/content/10.64898/2026.04.23.26351553v1
References:
Not explicitly provided in the text.
Image Credits:
Not mentioned.
Keywords:
Obesity, Cancer risk, Weight gain trajectory, Longitudinal cohort, Epidemiology, Life-course analysis, Liver cancer, Endometrial cancer, Esophageal adenocarcinoma, Renal cell carcinoma, Pituitary tumors, Sex differences, Obesity-related cancers.
Tags: adult weight dynamics and malignanciesadult weight gain and cancer riskcancer risk from weight changes over life courseEuropean Congress on Obesity 2026 researchexcess adiposity and cancer incidenceimpact of progressive weight increase on cancerlongitudinal weight trajectories and cancerLund University cancer studyobesity and metabolic consequencesobesity as oncogenic driverobesity-linked cancers epidemiologyobesity-related cancer types
